A study undertaken by GfK Market Access on behalf of the European Biosimilars Group, a sector group of EGA, about the future sustainability of the biosimilar medicines market.
Bron: GfK NOP Limited
Het belang van de patiënten staat voorop
A study undertaken by GfK Market Access on behalf of the European Biosimilars Group, a sector group of EGA, about the future sustainability of the biosimilar medicines market.
Bron: GfK NOP Limited
Volg ons via: